71-9509 – Direct agreement; sale or transfer; written consent.
71-9509. Direct agreement; sale or transfer; written consent. A direct agreement shall not be sold or transferred by either party without the written consent of the other party to the direct agreement. Source Laws 2016, LB817, § 9.
71-9510 – Direct provider; acceptance of payments from medical assistance program.
71-9510. Direct provider; acceptance of payments from medical assistance program. Subject to the restrictions established in the Direct Primary Care Agreement Act, a direct provider may accept payment of direct service charges directly or indirectly from the medical assistance program under the Medical Assistance Act or any entity contracting with the State of Nebraska to […]
71-9511 – Direct provider; primary care services; payment.
71-9511. Direct provider; primary care services; payment. A direct provider may provide primary care services to a patient who is not a party to a direct agreement with that provider and may receive payment for the services. Source Laws 2016, LB817, § 11.
71-9601 – Act, how cited.
71-9601. Act, how cited. Sections 71-9601 to 71-9611 shall be known and may be cited as the Investigational Drug Use Act. Source Laws 2018, LB117, § 1.
71-9602 – Terms, defined.
71-9602. Terms, defined. For purposes of the Investigational Drug Use Act: (1) Advanced illness means any progressive disease or medical or surgical condition that entails significant functional impairment, that is not considered by a treating physician to be reversible even with administration of federally approved and available treatments, and that, without life-sustaining procedures, would likely […]
71-9603 – Eligible patient.
71-9603. Eligible patient. To be an eligible patient under the Investigational Drug Use Act, a person shall: (1) Have an advanced illness, attested by the person’s treating physician; (2) Have considered all other treatment options approved by the United States Food and Drug Administration at the time; (3) Have a recommendation from his or her […]
71-9604 – Written informed consent; contents.
71-9604. Written informed consent; contents. To be acceptable under the Investigational Drug Use Act, a written, informed consent shall consist of a signed writing executed by an eligible patient, or his or her parent or legal guardian if the eligible patient is a minor, and attested to by the eligible patient’s treating physician, that: (1) […]
71-9302 – Terms, defined.
71-9302. Terms, defined. For purposes of the Home Care Consumer Bill of Rights Act: (1) Home care consumer means any person who receives home care services and who is (a) sixty years of age or older or (b) a person with disabilities and is younger than sixty years of age. Home care consumer shall also […]
71-9504 – Direct agreement; requirements; notice; copy to direct patient.
71-9504. Direct agreement; requirements; notice; copy to direct patient. (1) In order to be a valid direct agreement for purposes of the Direct Primary Care Agreement Act, a direct agreement between a direct provider and a direct patient or the patient’s representative in which the direct provider charges a direct service charge as consideration for […]
71-9303 – Minor child; incapacitated person; representation; assistance in securing rights.
71-9303. Minor child; incapacitated person; representation; assistance in securing rights. (1) A home care consumer who is a minor child shall be represented by his or her parent or guardian. Such parent or guardian shall act on behalf of the minor child in securing the minor child’s rights under the Home Care Consumer Bill of […]